News | September 16, 2021
Lupin to settle litigations over diabetes drug
The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval
The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
Turnover of API division of ISLL stood at Rs 856.58 crore
Subscribe To Our Newsletter & Stay Updated
